Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Explore essential factors to consider when choosing cash back credit cards. Make informed decisions to maximize your rewards.
23,660 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Bitcoin faces a tough test as ETF outflows converge with rising yields and a global risk-on mood. The phrase bitcoin ...
With year-end approaching, tax experts say the biggest savings come from timing income and deductions. The core idea ...
RH is poised to release Q1 results after the bell, with investors watching for margins, international exposure, and t...
With stock markets choppy and inflation easing, a growing number of financial planners urge a bridge strategy: withdr...
Microsoft stock remains volatile in mid-2026 as AI momentum collides with rising capex and a securities suit. Yet the...
AI jitters are turning discount chains and shampoo makers into the market’s hottest trade, upending traditional defen...
Lumen Technologies plans to shave $1B in annual network costs by 2027, driven by AI-enabled operations and a broader ...
Today’s energy-focused market action shows how volatile solar stocks can be when short-seller whispers collide with b...
As debt pressures mount, Ray Dalio warns the stock market may be flirting with bubble-like extremes seen before the 1...
A viral clash between a pop icon and political messaging reveals practical money lessons for everyday investors. Here...
NovaCore Technologies enters the second half of 2026 with a multi-year backlog, AI revenue momentum, and cloud growth...